Literature DB >> 15555669

Spina bifida.

Laura E Mitchell1, N Scott Adzick, Jeanne Melchionne, Patrick S Pasquariello, Leslie N Sutton, Alexander S Whitehead.   

Abstract

Spina bifida results from failure of fusion of the caudal neural tube, and is one of the most common malformations of human structure. The causes of this disorder are heterogeneous and include chromosome abnormalities, single gene disorders, and teratogenic exposures. However, the cause is not known in most cases. Up to 70% of spina bifida cases can be prevented by maternal, periconceptional folic acid supplementation. The mechanism underlying this protective effect is unknown, but it is likely to include genes that regulate folate transport and metabolism. Individuals with spina bifida need both surgical and medical management. Although surgical closure of the malformation is generally done in the neonatal period, a randomised clinical trial to assess in utero closure of spina bifida has been initiated in the USA. Medical management is a lifelong necessity for individuals with spina bifida, and should be provided by a multidisciplinary team.

Entities:  

Mesh:

Year:  2004        PMID: 15555669     DOI: 10.1016/S0140-6736(04)17445-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  100 in total

1.  In utero Repair of Myelomeningocele: Rationale, Initial Clinical Experience and a Randomized Controlled Prospective Clinical Trial.

Authors:  Enrico Danzer; Alan W Flake
Journal:  Neuroembryology Aging       Date:  2008-02-26

2.  Improved survival among children with spina bifida in the United States.

Authors:  Mikyong Shin; James E Kucik; Csaba Siffel; Chengxing Lu; Gary M Shaw; Mark A Canfield; Adolfo Correa
Journal:  J Pediatr       Date:  2012-06-23       Impact factor: 4.406

3.  Perineal sensation: an important predictor of long-term outcome in open spina bifida.

Authors:  P Oakeshott; G M Hunt; R H Whitaker; S Kerry
Journal:  Arch Dis Child       Date:  2006-08-30       Impact factor: 3.791

4.  Folate and homocysteine phenotypes: Comparative findings using research and clinical laboratory data.

Authors:  Laura E Mitchell; Megan Morales; Stefanie Khartulyari; Yuehua Huang; Kristen Murphy; Minghua Mei; Joan M Von Feldt; Ian A Blair; Alexander S Whitehead
Journal:  Clin Biochem       Date:  2009-05-08       Impact factor: 3.281

5.  Ultrasound-guided neuroaxial anesthesia: accurate diagnosis of spina bifida occulta by ultrasonography.

Authors:  Yusuke Asakura; Nobuhisa Kandatsu; Atsushi Hashimoto; Mitsuhiro Kamiya; Manabu Akashi; Toru Komatsu
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

Review 6.  The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects.

Authors:  Anne M Molloy; Lawrence C Brody; James L Mills; John M Scott; Peadar N Kirke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

Review 7.  Prospects for fetal surgery.

Authors:  N Scott Adzick
Journal:  Early Hum Dev       Date:  2013-10-04       Impact factor: 2.079

8.  Non-neural surface ectodermal rosette formation and F-actin dynamics drive mammalian neural tube closure.

Authors:  Chengji J Zhou; Yu Ji; Kurt Reynolds; Moira McMahon; Michael A Garland; Shuwen Zhang; Bo Sun; Ran Gu; Mohammad Islam; Yue Liu; Tianyu Zhao; Grace Hsu; Janet Iwasa
Journal:  Biochem Biophys Res Commun       Date:  2020-04-02       Impact factor: 3.575

9.  Assessing awareness, knowledge and use of folic acid in Kansas women between the ages of 18 and 44 years.

Authors:  Glynda F Sharp; Lorenda A Naylor; Jinwen Cai; Melissa L Hyder; Pradeep Chandra; V James Guillory
Journal:  Matern Child Health J       Date:  2008-09-23

10.  Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells.

Authors:  Carolyn M Summers; Andrea L Hammons; Jasbir Arora; Suhong Zhang; Jeanine Jochems; Ian A Blair; Alexander S Whitehead
Journal:  Eur J Pharmacol       Date:  2014-03-18       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.